BioLife Solutions, Inc. (BLFS)
NASDAQ: BLFS · Real-Time Price · USD
20.12
-0.56 (-2.69%)
Mar 5, 2026, 11:21 AM EST - Market open
BioLife Solutions Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for BioLife Solutions stock has a target of 32, which predicts an increase of 59.09% from the current stock price of 20.12.
Analyst Consensus: Strong Buy
* Price targets were last updated on Dec 29, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for BioLife Solutions is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 2 | 1 | 1 | 1 | 1 |
| Buy | 2 | 2 | 1 | 1 | 1 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 4 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +59.09% | Dec 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $32 | Strong Buy | Reiterates | $32 | +59.09% | Nov 24, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $30 → $32 | Strong Buy | Maintains | $30 → $32 | +59.09% | Aug 8, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +49.14% | May 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $27 → $30 | Strong Buy | Maintains | $27 → $30 | +49.14% | Mar 6, 2025 |
Financial Forecast
Revenue This Year
114.69M
from 96.21M
Increased by 19.20%
Revenue Next Year
135.41M
from 114.69M
Increased by 18.07%
EPS This Year
0.15
from -0.10
EPS Next Year
0.41
from 0.15
Increased by 176.13%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 119.7M | 144.2M | |||
| Avg | 114.7M | 135.4M | |||
| Low | 106.6M | 126.9M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 24.4% | 25.7% | |||
| Avg | 19.2% | 18.1% | |||
| Low | 10.8% | 10.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.38 | 0.54 | |
| Avg | 0.15 | 0.41 | |
| Low | 0.03 | 0.32 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 257.9% | |
| Avg | - | 176.1% | |
| Low | - | 116.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.